Subject: Re: Transitions
From: Tengiz Tsertsvadze <[email-masked]>
To: "Averhoff, Francisco (CDC/DDID/NCIRD/ID)" <[email-masked]>
Cc: "Gamkrelidze, Amiran (CDC ncdc.ge)" <[email-masked]>, Maia Tsereteli <[email-masked]>, Ana Aslanikashvili <[email-masked]>, akaki abutidze <[email-masked]>, Nikoloz Chkhartishvili <[email-masked]>, Nikoloz Chkhartishvili <[email-masked]>, jaba zarqua <[email-masked]>, Maia Butsashvili <[email-masked]>, George Kamkamidze <[email-masked]>, Ekaterine Adamia <[email-masked]>, Tamar Gabunia <[email-masked]>
Date: Tue, 18 Aug 2020 18:05:36 +0000

Dear Dr. Averhoff,

We very much regret to hear that you left the CDC Division
of Viral Hepatitis. You are well aware of our very special respect to you. You
were a leading architect of Georgia’s hepatitis C elimination program and your
personal contribution in the initiation and implementation of the program has
been tremendous. Let me assure you that without your leadership this program
would not be as successful as it is at present.

We are very privileged to know you. It has been a great honor
and pleasure to collaborate with you.

We are sure that your contribution will be significant in supporting
COVID 19 response and we wish you all the success in your new challenging position.

We hope to have opportunities to meet you in the near future.

Thank you once again for your valuable support to Georgia’s
hepatitis C elimination program and to the health of Georgian people.

Sincerely,

Tengiz Tsertsvadze

On Tue, Aug 11, 2020 at 7:37 PM Averhoff, Francisco (CDC/DDID/NCIRD/ID) <[email-masked]> wrote:

Dear Friends and Colleagues,

I wanted to advise you that I have left the CDC Division of Viral Hepatitis as of 1 August 2020.  You have all done an amazing job with HCV Elimination, it has been my honor and privilege to work with you all.  The support from CDC will
continue, of course, with the Atlanta and Georgia based teams, I look forward to the final success!  I am staying and supporting the CDC COVID-19 response, which has been a huge challenge, and we again need to learn lessons from Georgia, just as we have for
HCV Elimination.

My email address remains.  Thank you again for the privilege of working with you all and the opportunity to get to know you as friends and visit your beautiful and lovely country.

Best regards, FA

Francisco Averhoff MD, MPH

CAPT US Public Health Service

COVID 19 Response

Serology Coordination

Centers for Disease Control and Prevention

1600 Clifton Road

Atlanta, GA 30333

phone: 404-718-8501

e-mail:
[email-masked]